Gates Medical Research Institute
Tracked across 3 events · 28 articles · First seen Jul 02, 2026 · Last active Aug 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Sponsor of Phase 3 trial and technology transfer partner; key driver of vaccine development.
Jul 16, 2026 · 14 articles
Tech
Altor BioScience submitted a Clinical Trial Application to the South Africa — South African Health Products Regulatory Authority (SAHPRA) for a global pediatric Phase 1b clinical trial of RSM01, a respiratory syncytial virus (RSV) preventive…
Impact: Gates MRI licensed RSM01 to Altor BioScience and conducted early research and Phase 1a. The trial advances a candidate from its portfolio, potentially validating its research.
Jul 20, 2026 · 7 articles
Tech
Impact: Gates Medical Research Institute has an agreement with Altor BioScience for the development of an RSV antibody therapy, showcasing ongoing partnerships in medical research.
Jul 02, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Gates Medical Research Institute live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard